PCR-sequencing is a complementary method to amplification refractory mutation system for EGFR gene mutation analysis in FFPE samples-Reference-Cited by-同舟云学术

PCR-sequencing is a complementary method to amplification refractory mutation system for EGFR gene mutation analysis in FFPE samples

Published:2015-12 Issue:3 Volume:99 Page:581-589
ISSN:0014-4800
Container-title:Experimental and Molecular Pathology
language:en
Short-container-title:Experimental and Molecular Pathology

Author:

Jiang Junchang,Wang Chunhua,Yu Xiaoli,Sheng Danli,Zuo Chen,Ren Minpu,Wu Yaqin,Shen Jie,Jin Mei,Xu Songxiao

Funder

National Natural Science Foundation of China

Department of Education, Zhejiang Province, China

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Pathology and Forensic Medicine

Reference31 articles.

1. Primary and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer: an update;Ayoola;Cancer Investig.,2012

2. Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptor;Finlay;J. Med. Chem.,2014

3. Trend analyses on the differences of lung cancer incidence between gender, area and average age in China during 1989–2008;Han;Zhongguo Fei Ai Za Zhi,2013

4. Overview of molecular genetic diagnosis;Harada;Curr Protoc Hum Genet.,2013

5. Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer;Hirsch;J. Clin. Oncol.,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient ten-gene analysis of NSCLC tissue samples by next-generation sequencing;Pathology - Research and Practice;2019-05

2. Methodological comparison of the allele refractory mutation system and direct sequencing for detecting EGFR mutations in NSCLC, and the association of EGFR mutations with patient characteristics;Oncology Letters;2018-05-22

3. Mutation abundance affects the therapeutic efficacy of EGFR-TKI in patients with advanced lung adenocarcinoma: A retrospective analysis;Cancer Biology & Therapy;2018-04-13